Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective

88Citations
Citations of this article
148Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Abstract: Ubiquitin signaling is a sequence of events driving the fate of a protein based on the type of ubiquitin modifications attached. In the case of neurodegenerative diseases, ubiquitin signaling is mainly associated with degradation signals to process aberrant proteins, which form aggregates often fatal for the brain cells. This signaling is often perturbed by the aggregates themselves and leads to the accumulation of toxic aggregates and inclusion bodies that are deleterious due to a toxic gain of function. Decrease in quality control pathways is often seen with age and is a critical onset for the development of neurodegeneration. Many aggregates are now thought to propagate in a prion-like manner, where mutated proteins acting like seeds are transitioning from cell to cell, converting normal proteins to toxic aggregates. Modulation of ubiquitin signaling, by stimulating ubiquitin ligase activation, is a potential therapeutic strategy to treat patients with neurodegeneration diseases.

Cite

CITATION STYLE

APA

Le Guerroué, F., & Youle, R. J. (2021, February 1). Ubiquitin signaling in neurodegenerative diseases: an autophagy and proteasome perspective. Cell Death and Differentiation. Springer Nature. https://doi.org/10.1038/s41418-020-00667-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free